Degradation of Tyrosine Hydroxylase by the Ubiquitin-Proteasome System in the Pathogenesis of Parkinson's Disease and Dopa-Responsive Dystonia

被引:43
|
作者
Kawahata, Ichiro [1 ]
Fukunaga, Kohji [1 ]
机构
[1] Tohoku Univ, Grad Sch Pharmaceut Sci, Dept Pharmacol, Sendai, Miyagi 9808578, Japan
基金
日本学术振兴会;
关键词
Parkinson's disease; dopa-responsive dystonia; tyrosine hydroxylase; alpha-synuclein; fatty acid-binding protein 3; ubiquitination; proteasomal degradation; ubiquitin-proteasome system; PROTEIN PHOSPHATASE 2A; CHAPERONE-MEDIATED AUTOPHAGY; MUTANT ALPHA-SYNUCLEIN; COMPLEX I DEFICIENCY; N-TERMINAL REGION; SYNERGISTIC INTERACTIONS; AFFINITY PURIFICATION; ALZHEIMERS-DISEASE; SUBSTANTIA-NIGRA; MESSENGER-RNA;
D O I
10.3390/ijms21113779
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Nigrostriatal dopaminergic systems govern physiological functions related to locomotion, and their dysfunction leads to movement disorders, such as Parkinson's disease and dopa-responsive dystonia (Segawa disease). Previous studies revealed that expression of the gene encoding nigrostriatal tyrosine hydroxylase (TH), a rate-limiting enzyme of dopamine biosynthesis, is reduced in Parkinson's disease and dopa-responsive dystonia; however, the mechanism of TH depletion in these disorders remains unclear. In this article, we review the molecular mechanism underlying the neurodegeneration process in dopamine-containing neurons and focus on the novel degradation pathway of TH through the ubiquitin-proteasome system to advance our understanding of the etiology of Parkinson's disease and dopa-responsive dystonia. We also introduce the relation of alpha-synuclein propagation with the loss of TH protein in Parkinson's disease as well as anticipate therapeutic targets and early diagnosis of these diseases.
引用
收藏
页数:19
相关论文
共 50 条
  • [21] GCH1 mutations in dopa-responsive dystonia and Parkinson's disease
    Yoshino, Hiroyo
    Nishioka, Kenya
    Li, Yuanzhe
    Oji, Yutaka
    Oyama, Genko
    Hatano, Taku
    Machida, Yutaka
    Shimo, Yasushi
    Hayashida, Arisa
    Ikeda, Aya
    Mogushi, Kaoru
    Shibagaki, Yasuro
    Hosaka, Ai
    Iwanaga, Hiroshi
    Fujitake, Junko
    Ohi, Takekazu
    Miyazaki, Daigo
    Sekijima, Yoshiki
    Oki, Mitsuaki
    Kusaka, Hirofumi
    Fujimoto, Ken-ichi
    Ugawa, Yoshikazu
    Funayama, Manabu
    Hattori, Nobutaka
    JOURNAL OF NEUROLOGY, 2018, 265 (08) : 1860 - 1870
  • [22] Genetics and biochemistry of dopa-responsive dystonia: Significance of striatal tyrosine hydroxylase protein loss
    Furukawa, Y
    PARKINSON'S DISEASE, 2003, 91 : 401 - 410
  • [23] Dopa-Responsive Dystonia: Guanosine Triphosphate Cyclohydrolase 1, Tyrosine Hydroxylase, and Sepiapterin Reductase
    Pitton, Jamir
    Fornari Caprara, Ana Leticia
    IBNOSINA JOURNAL OF MEDICINE AND BIOMEDICAL SCIENCES, 2021, 13 (01): : 44 - 45
  • [24] Novel compound heterozygous tyrosine hydroxylase mutations in two DOPA-responsive dystonia patients
    Haugarvoll, K.
    Bindoff, L.
    PARKINSONISM & RELATED DISORDERS, 2009, 15 : S43 - S43
  • [25] Exploring the Role of Ubiquitin-Proteasome System in Parkinson's Disease
    Behl, Tapan
    Kumar, Sachin
    Althafar, Ziyad M.
    Sehgal, Aayush
    Singh, Sukhbir
    Sharma, Neelam
    Badavath, Vishnu Nayak
    Yadav, Shivam
    Bhatia, Saurabh
    Al-Harrasi, Ahmed
    Almoshari, Yosif
    Almikhlafi, Mohannad A.
    Bungau, Simona
    MOLECULAR NEUROBIOLOGY, 2022, 59 (07) : 4257 - 4273
  • [26] A critical evaluation of the ubiquitin-proteasome system in Parkinson's disease
    Cook, Casey
    Petrucelli, Leonard
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2009, 1792 (07): : 664 - 675
  • [27] Novel GCH1 variant in Dopa-responsive dystonia and Parkinson's disease
    Lewthwaite, A. J.
    Lambert, T. D.
    Rolfe, E. B.
    Olgiati, S.
    Quadri, M.
    Simons, E. J.
    Morrison, K. E.
    Bonifati, V.
    Nicholl, D. J.
    PARKINSONISM & RELATED DISORDERS, 2015, 21 (04) : 394 - 397
  • [28] Ubiquitin-proteasome system and Parkinson's diseases
    Betarbet, R
    Sherer, TB
    Greenamyre, JT
    EXPERIMENTAL NEUROLOGY, 2005, 191 : S17 - S27
  • [29] Personalized Medicine to Improve Treatment of Dopa-Responsive Dystonia-A Focus on Tyrosine Hydroxylase Deficiency
    Nygaard, Gyrid
    Szigetvari, Peter D.
    Grindheim, Ann Kari
    Ruoff, Peter
    Martinez, Aurora
    Haavik, Jan
    Kleppe, Rune
    Flydal, Marte, I
    JOURNAL OF PERSONALIZED MEDICINE, 2021, 11 (11):
  • [30] Dopa-responsive dystonia caused by tyrosine hydroxylase deficiency Three cases report and literature review
    Dong, Han-Yu
    Feng, Jun-Yan
    Yue, Xiao-Jing
    Shan, Ling
    Jia, Fei-Yong
    MEDICINE, 2020, 99 (33) : E21753